 | • レポートコード：MR2211MG12802 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、無菌輸液調剤薬局のグローバル市場規模と予測を記載しています。・無菌輸液調剤薬局のグローバル市場：売上、2017年-2022年、2023年-2028年 ・無菌輸液調剤薬局のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 無菌輸液調剤薬局のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「抗感染薬」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 無菌輸液調剤薬局のグローバル主要企業は、Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangliなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、無菌輸液調剤薬局のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の無菌輸液調剤薬局市場：タイプ別、2017年-2022年、2023年-2028年 世界の無菌輸液調剤薬局市場：タイプ別市場シェア、2021年 ・抗感染薬、血液因子、免疫療法、その他 世界の無菌輸液調剤薬局市場：用途別、2017年-2022年、2023年-2028年 世界の無菌輸液調剤薬局市場：用途別市場シェア、2021年 ・18歳以下消費者、19-44歳消費者、45-64歳消費者、65歳以上消費者 世界の無菌輸液調剤薬局市場：地域・国別、2017年-2022年、2023年-2028年 世界の無菌輸液調剤薬局市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における無菌輸液調剤薬局のグローバル売上、2017年-2022年 ・主要企業における無菌輸液調剤薬局のグローバル売上シェア、2021年 ・主要企業における無菌輸液調剤薬局のグローバル販売量、2017年-2022年 ・主要企業における無菌輸液調剤薬局のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangli ************************************************************* ・調査・分析レポートの概要 無菌輸液調剤薬局市場の定義 市場セグメント 世界の無菌輸液調剤薬局市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の無菌輸液調剤薬局市場規模 世界の無菌輸液調剤薬局市場規模：2021年 VS 2028年 世界の無菌輸液調剤薬局市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの無菌輸液調剤薬局の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の無菌輸液調剤薬局製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：抗感染薬、血液因子、免疫療法、その他 無菌輸液調剤薬局のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：18歳以下消費者、19-44歳消費者、45-64歳消費者、65歳以上消費者 無菌輸液調剤薬局の用途別グローバル売上・予測 ・地域別市場分析 地域別無菌輸液調剤薬局市場規模 2021年と2028年 地域別無菌輸液調剤薬局売上・予測 北米市場 - アメリカの無菌輸液調剤薬局市場規模2017年-2028年 - カナダの無菌輸液調剤薬局市場規模2017年-2028年 - メキシコの無菌輸液調剤薬局市場規模2017年-2028年 ヨーロッパ市場 - ドイツの無菌輸液調剤薬局市場規模2017年-2028年 - フランスの無菌輸液調剤薬局市場規模2017年-2028年 - イギリスの無菌輸液調剤薬局市場規模2017年-2028年 - イタリアの無菌輸液調剤薬局市場規模2017年-2028年 - ロシアの無菌輸液調剤薬局市場規模2017年-2028年 アジア市場 - 中国の無菌輸液調剤薬局市場規模2017年-2028年 - 日本の無菌輸液調剤薬局市場規模2017年-2028年 - 韓国の無菌輸液調剤薬局市場規模2017年-2028年 - 東南アジアの無菌輸液調剤薬局市場規模2017年-2028年 - インドの無菌輸液調剤薬局市場規模2017年-2028年 南米市場 - ブラジルの無菌輸液調剤薬局市場規模2017年-2028年 - アルゼンチンの無菌輸液調剤薬局市場規模2017年-2028年 中東・アフリカ市場 - トルコの無菌輸液調剤薬局市場規模2017年-2028年 - イスラエルの無菌輸液調剤薬局市場規模2017年-2028年 - サウジアラビアの無菌輸液調剤薬局市場規模2017年-2028年 - UAEの無菌輸液調剤薬局市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangli ... |
There’s a higher risk of infection or serious problems if contaminants get into the medication. So, sterile compounds are made in a special environment with additional requirements to minimize this risk.
This report contains market size and forecasts of Sterile Infusions Compounding Pharmacy in Global, including the following market information:
Global Sterile Infusions Compounding Pharmacy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sterile Infusions Compounding Pharmacy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-infectives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sterile Infusions Compounding Pharmacy include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sterile Infusions Compounding Pharmacy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sterile Infusions Compounding Pharmacy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, by Type, 2021 (%)
Anti-infectives
Blood Factors
Immunotherapies
Others
Global Sterile Infusions Compounding Pharmacy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, by Application, 2021 (%)
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Global Sterile Infusions Compounding Pharmacy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sterile Infusions Compounding Pharmacy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sterile Infusions Compounding Pharmacy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
1 Introduction to Research & Analysis Reports
1.1 Sterile Infusions Compounding Pharmacy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sterile Infusions Compounding Pharmacy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sterile Infusions Compounding Pharmacy Overall Market Size
2.1 Global Sterile Infusions Compounding Pharmacy Market Size: 2021 VS 2028
2.2 Global Sterile Infusions Compounding Pharmacy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sterile Infusions Compounding Pharmacy Players in Global Market
3.2 Top Global Sterile Infusions Compounding Pharmacy Companies Ranked by Revenue
3.3 Global Sterile Infusions Compounding Pharmacy Revenue by Companies
3.4 Top 3 and Top 5 Sterile Infusions Compounding Pharmacy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sterile Infusions Compounding Pharmacy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sterile Infusions Compounding Pharmacy Players in Global Market
3.6.1 List of Global Tier 1 Sterile Infusions Compounding Pharmacy Companies
3.6.2 List of Global Tier 2 and Tier 3 Sterile Infusions Compounding Pharmacy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Sterile Infusions Compounding Pharmacy Market Size Markets, 2021 & 2028
4.1.2 Anti-infectives
4.1.3 Blood Factors
4.1.4 Immunotherapies
4.1.5 Others
4.2 By Type – Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
4.2.1 By Type – Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
4.2.2 By Type – Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
4.2.3 By Type – Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sterile Infusions Compounding Pharmacy Market Size, 2021 & 2028
5.1.2 Consumers Aged 18 and Younger
5.1.3 Consumers Aged 19 to 44
5.1.4 Consumers Aged 45 to 64
5.1.5 Consumers Aged 65 and Older
5.2 By Application – Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
5.2.1 By Application – Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
5.2.2 By Application – Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
5.2.3 By Application – Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Sterile Infusions Compounding Pharmacy Market Size, 2021 & 2028
6.2 By Region – Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
6.2.1 By Region – Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
6.2.2 By Region – Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
6.2.3 By Region – Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
6.3.2 US Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.3.3 Canada Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.3.4 Mexico Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
6.4.2 Germany Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.3 France Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.4 U.K. Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.5 Italy Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.6 Russia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.7 Nordic Countries Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4.8 Benelux Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
6.5.2 China Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5.3 Japan Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5.4 South Korea Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5.5 Southeast Asia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5.6 India Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
6.6.2 Brazil Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.6.3 Argentina Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
6.7.2 Turkey Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.7.3 Israel Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.7.4 Saudi Arabia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.7.5 UAE Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
7 Players Profiles
7.1 Baxter
7.1.1 Baxter Corporate Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Sterile Infusions Compounding Pharmacy Major Product Offerings
7.1.4 Baxter Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.1.5 Baxter Key News
7.2 B. Braun
7.2.1 B. Braun Corporate Summary
7.2.2 B. Braun Business Overview
7.2.3 B. Braun Sterile Infusions Compounding Pharmacy Major Product Offerings
7.2.4 B. Braun Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.2.5 B. Braun Key News
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Corporate Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Major Product Offerings
7.3.4 Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.3.5 Fresenius Kabi Key News
7.4 Kelun Pharma
7.4.1 Kelun Pharma Corporate Summary
7.4.2 Kelun Pharma Business Overview
7.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Major Product Offerings
7.4.4 Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.4.5 Kelun Pharma Key News
7.5 Otsuka Pharmaceutical
7.5.1 Otsuka Pharmaceutical Corporate Summary
7.5.2 Otsuka Pharmaceutical Business Overview
7.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.5.4 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.5.5 Otsuka Pharmaceutical Key News
7.6 JW Pharmaceutical
7.6.1 JW Pharmaceutical Corporate Summary
7.6.2 JW Pharmaceutical Business Overview
7.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.6.4 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.6.5 JW Pharmaceutical Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Sterile Infusions Compounding Pharmacy Major Product Offerings
7.7.4 Pfizer Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.8.4 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 Haisco Pharmaceutical Group
7.9.1 Haisco Pharmaceutical Group Corporate Summary
7.9.2 Haisco Pharmaceutical Group Business Overview
7.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Major Product Offerings
7.9.4 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.9.5 Haisco Pharmaceutical Group Key News
7.10 King York
7.10.1 King York Corporate Summary
7.10.2 King York Business Overview
7.10.3 King York Sterile Infusions Compounding Pharmacy Major Product Offerings
7.10.4 King York Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.10.5 King York Key News
7.11 Cisen
7.11.1 Cisen Corporate Summary
7.11.2 Cisen Business Overview
7.11.3 Cisen Sterile Infusions Compounding Pharmacy Major Product Offerings
7.11.4 Cisen Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.11.5 Cisen Key News
7.12 Lummy
7.12.1 Lummy Corporate Summary
7.12.2 Lummy Business Overview
7.12.3 Lummy Sterile Infusions Compounding Pharmacy Major Product Offerings
7.12.4 Lummy Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.12.5 Lummy Key News
7.13 Grand Life Sciences
7.13.1 Grand Life Sciences Corporate Summary
7.13.2 Grand Life Sciences Business Overview
7.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Major Product Offerings
7.13.4 Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.13.5 Grand Life Sciences Key News
7.14 Medisan
7.14.1 Medisan Corporate Summary
7.14.2 Medisan Business Overview
7.14.3 Medisan Sterile Infusions Compounding Pharmacy Major Product Offerings
7.14.4 Medisan Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.14.5 Medisan Key News
7.15 BBCA Pharmaceutical
7.15.1 BBCA Pharmaceutical Corporate Summary
7.15.2 BBCA Pharmaceutical Business Overview
7.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.15.4 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.15.5 BBCA Pharmaceutical Key News
7.16 Biokin Pharmaceutical
7.16.1 Biokin Pharmaceutical Corporate Summary
7.16.2 Biokin Pharmaceutical Business Overview
7.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.16.4 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.16.5 Biokin Pharmaceutical Key News
7.17 Xi’an Libang Pharmaceutical
7.17.1 Xi’an Libang Pharmaceutical Corporate Summary
7.17.2 Xi’an Libang Pharmaceutical Business Overview
7.17.3 Xi’an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.17.4 Xi’an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.17.5 Xi’an Libang Pharmaceutical Key News
7.18 Lionco Pharmaceutical
7.18.1 Lionco Pharmaceutical Corporate Summary
7.18.2 Lionco Pharmaceutical Business Overview
7.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
7.18.4 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.18.5 Lionco Pharmaceutical Key News
7.19 China Meheco Kangli
7.19.1 China Meheco Kangli Corporate Summary
7.19.2 China Meheco Kangli Business Overview
7.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Major Product Offerings
7.19.4 China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
7.19.5 China Meheco Kangli Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer